Immunotherapy Co. Must Pay NY Broker $2.5M Arb. Award
A New York federal judge has ordered an immunotherapy development company to pay $2.5 million to a brokerage firm that placed its securities with investor-customers in 2017, confirming a decision issued...To view the full article, register now.
Already a subscriber? Click here to view full article